Pfizer Ltd vs Procter Gamble Health Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 04, 2026

Key Highlights

The Latest Trading Price of Pfizer Ltd is ₹ 4708 as of 30 Apr 15:30 . The p/e ratio of Pfizer Ltd changed from 23.9 to 34.8 over 5 quarters. This represents a CAGR of 35.07% The p/e ratio of Procter & Gamble Health Ltd changed from 52.5 to 0 over 9 quarters. This represents a CAGR of -100.00% The market cap of Pfizer Ltd changed from ₹ 18317 crore to ₹ 19184 crore over 5 quarters. This represents a CAGR of 3.77% The market cap of Procter & Gamble Health Ltd changed from ₹ 9285 crore to ₹ 0 crore over 9 quarters. This represents a CAGR of -100.00% The revenue of Pfizer Ltd for the Dec '25 is ₹ 683.24 crore as compare to the Sep '25 revenue of ₹ 684.19 crore. This represent the decline of -0.14% The revenue of Procter & Gamble Health Ltd for the Dec '25 is ₹ 378.22 crore as compare to the Sep '25 revenue of ₹ 329.87 crore. This represent the growth of 14.66% The ebitda of Pfizer Ltd for the Dec '25 is ₹ 208.2 crore as compare to the Sep '25 ebitda of ₹ 271.78 crore. This represent the decline of -23.39% The ebitda of Procter & Gamble Health Ltd for the Dec '25 is ₹ 114.82 crore as compare to the Sep '25 ebitda of ₹ 125.22 crore. This represent the decline of -8.31% The net profit of Pfizer Ltd changed from ₹ 127.6 crore to ₹ 141.84 crore over 7 quarters. This represents a CAGR of 6.23% The net profit of Procter & Gamble Health Ltd changed from ₹ 46.56 crore to ₹ 77.59 crore over 7 quarters. This represents a CAGR of 33.89% The dividend payout of Pfizer Ltd changed from 98.34 % to 29.04 % over 5 quarters. This represents a CAGR of -62.31% The dividend payout of Procter & Gamble Health Ltd changed from 122.06 % to 0 % over 9 quarters. This represents a CAGR of -100.00% .

About Pfizer Ltd

Pfizer Limited is engaged in manufacturing, marketing, trading and export of pharmaceutical products.
The Company offer a portfolio of 150 specialised medicines in 15 therapeutic areas across 4 business categories.
It has its own manufacturing facility at Goa and Thane.
It has the distinction of being the first pharmaceutical company in India to start clinical research.
The Company sells products in nearly 185 countries having 43 manufacturing sites globally.

About Procter & Gamble Health Ltd

Procter & Gamble Health Limited was erstwhile incorporated as E Merck (India) Limited in 1967.
The Company's name was changed from E Merck (India) Limited to Merck Limited on March 27, 2002.
Later, the name of the Company was changed to Procter & Gamble Health Limited on 6 May, 2019.
The company was set up to take over the business of the Indian branch of Emeda Exports with all their assets and liabilities.
The company is a 51% subsidiary of German firm Merck KGaA, is a leading player in vitamin formulations. Procter & Gamble Health Limited is an Indian-based company principally engaged in the business of manufacturing and marketing of pharmaceuticals and chemicals.

FAQs for the comparison of Pfizer Ltd and Procter & Gamble Health Ltd

Which company has a larger market capitalization, Pfizer Ltd or Procter & Gamble Health Ltd?

Market cap of Pfizer Ltd is 21,538 Cr while Market cap of Procter & Gamble Health Ltd is 8,622 Cr

What are the key factors driving the stock performance of Pfizer Ltd and Procter & Gamble Health Ltd?

The stock performance of Pfizer Ltd and Procter & Gamble Health Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Pfizer Ltd and Procter & Gamble Health Ltd?

As of May 4, 2026, the Pfizer Ltd stock price is INR ₹4708.15. On the other hand, Procter & Gamble Health Ltd stock price is INR ₹5194.55.

How do dividend payouts of Pfizer Ltd and Procter & Gamble Health Ltd compare?

To compare the dividend payouts of Pfizer Ltd and Procter & Gamble Health Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.